1. Home
  2. GPUS vs RDHL Comparison

GPUS vs RDHL Comparison

Compare GPUS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • RDHL
  • Stock Information
  • Founded
  • GPUS 1969
  • RDHL 2009
  • Country
  • GPUS United States
  • RDHL Israel
  • Employees
  • GPUS N/A
  • RDHL N/A
  • Industry
  • GPUS
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • RDHL Health Care
  • Exchange
  • GPUS NYSE
  • RDHL Nasdaq
  • Market Cap
  • GPUS 4.8M
  • RDHL 3.8M
  • IPO Year
  • GPUS 1996
  • RDHL N/A
  • Fundamental
  • Price
  • GPUS $1.37
  • RDHL $2.03
  • Analyst Decision
  • GPUS
  • RDHL
  • Analyst Count
  • GPUS 0
  • RDHL 0
  • Target Price
  • GPUS N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • GPUS 8.6M
  • RDHL 19.2K
  • Earning Date
  • GPUS 08-15-2025
  • RDHL 04-10-2025
  • Dividend Yield
  • GPUS N/A
  • RDHL N/A
  • EPS Growth
  • GPUS N/A
  • RDHL N/A
  • EPS
  • GPUS N/A
  • RDHL N/A
  • Revenue
  • GPUS $93,318,000.00
  • RDHL $8,042,999.00
  • Revenue This Year
  • GPUS N/A
  • RDHL $381.91
  • Revenue Next Year
  • GPUS N/A
  • RDHL N/A
  • P/E Ratio
  • GPUS N/A
  • RDHL N/A
  • Revenue Growth
  • GPUS N/A
  • RDHL 23.17
  • 52 Week Low
  • GPUS $1.23
  • RDHL $1.71
  • 52 Week High
  • GPUS $11.73
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • RDHL 57.04
  • Support Level
  • GPUS N/A
  • RDHL $1.75
  • Resistance Level
  • GPUS N/A
  • RDHL $2.08
  • Average True Range (ATR)
  • GPUS 0.00
  • RDHL 0.09
  • MACD
  • GPUS 0.00
  • RDHL 0.03
  • Stochastic Oscillator
  • GPUS 0.00
  • RDHL 85.16

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: